iodoacetamide has been researched along with Disease Models, Animal in 26 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aims to describe the morphological alterations in the small and large intestines as well as the expression of some enterocyte enzymes and carriers in a rat model of iodoacetamide-induced colitis." | 7.73 | Morphological and biochemical alterations in the jejunum following iodoacetamide-induced colitis in rats. ( Assef, MD; Barada, K; Foltzer, CJ; Jurjus, A; Kedinger, M; Khoury, N; Reimund, JM, 2006) |
| " Our aim is to determine the antiinflammatory activity of deferiprone, an oral iron chelator, in experimental colitis and gastritis." | 7.70 | Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. ( Ablin, J; Karmeli, F; Okon, E; Rachmilewitz, D; Shalev, O, 1999) |
| "Nicotine treatment also significantly increased jejunal segmental weight." | 5.31 | Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats. ( Cohen, P; Eliakim, R; Heyman, SN; Karmeli, F; Rachmilewitz, D, 2001) |
| "Colitis was more severe in rats subjected to neonatal or adult capsaicin treatment, but was not affected by subdiaphragmatic vagotomy." | 5.31 | Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents. ( Barada, KA; Kafrouni, MI; Khoury, CI; Mourad, FH; Nassar, CF; Saade, NE; Szabo, SS, 2001) |
| " Subsequently, its protective effect in indomethacin and iodoacetamide induced colitis in rats (45, 90, 180, 270 mg/kg) and acetic acid induced colitis in mice (65, 130, 250, 500 mg/kg) was assessed." | 3.77 | Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice. ( Jagtap, AG; Niphadkar, PV; Phadke, AS, 2011) |
| "This study aims to describe the morphological alterations in the small and large intestines as well as the expression of some enterocyte enzymes and carriers in a rat model of iodoacetamide-induced colitis." | 3.73 | Morphological and biochemical alterations in the jejunum following iodoacetamide-induced colitis in rats. ( Assef, MD; Barada, K; Foltzer, CJ; Jurjus, A; Kedinger, M; Khoury, N; Reimund, JM, 2006) |
| " In this study, acetic acid colitis was induced in rats with portal vein ligation and in control groups, and iodoacetamide colitis was induced in rats with partial portal vein ligation and cirrhosis due to bile duct ligation and in control groups." | 3.72 | Experimental colitis in rats with portal hypertension and liver disease. ( Ackerman, Z; Cohen, P; Karmeli, F; Rachmilewitz, D, 2003) |
| "Both VSL#3 and LGG significantly ameliorated colitis induced by the sulfhydryl-blocker iodoacetamide, but had no effect on the immune-mediated DNBS-induced colitis." | 3.71 | Variable response to probiotics in two models of experimental colitis in rats. ( Brigidi, P; Campieri, M; Eliakim, R; Gionchetti, P; Karmeli, F; Morgenstern, S; Rachmilewitz, D; Shibolet, O; Swennen, E, 2002) |
| "Enoxaparin and heparin significantly ameliorated the severity of dinitrobenzene sulphonic acid- and iodoacetamide-induced colitis as demonstrated by a decrease in mucosal lesion area, colonic weight and mucosal myeloperoxidase and nitric oxide synthase activities." | 3.71 | Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats. ( Brazowski, E; Dotan, I; Halpern, Z; Hershkoviz, R; Karmeli, F; Peled, Y; Rachmilewitz, D, 2001) |
| "A rat model of experimental colitis and jejunitis induced by iodoacetamide (IA), a sulphydryl blocker is accompanied by increased leukotriene, prostaglandin E2 (PGE2) generation, and nitric oxide synthase (NOS) activity." | 3.70 | Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle. ( Alpers, DH; Cohen, P; Eliakim, R; Karmeli, F; Rachmilewitz, D; Shao, JS, 1999) |
| " Our aim is to determine the antiinflammatory activity of deferiprone, an oral iron chelator, in experimental colitis and gastritis." | 3.70 | Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. ( Ablin, J; Karmeli, F; Okon, E; Rachmilewitz, D; Shalev, O, 1999) |
| "Treatment with quinpirole decreased the size of colonic lesions in rats with iodoacetamide-induced UC (p < 0." | 1.42 | Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease. ( Ahluwalia, A; Deng, X; Ostapchenko, L; Paunovic, B; Prysiazhniuk, A; Sandor, Z; Szabo, S; Tarnawski, A; Tolstanova, G, 2015) |
| "The experimental ulcerative colitis model used in the present study resembles, to a great extent, the human disease." | 1.35 | Inflammatory bowel disease in rats: bacterial and chemical interaction. ( Barada, K; Freund, JN; Hajj Hussein, IA; Jurjus, A; Jurjus, RA; Karam, W; Mostafa, MH; Tohme, R, 2008) |
| "Nicotine treatment also significantly increased jejunal segmental weight." | 1.31 | Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats. ( Cohen, P; Eliakim, R; Heyman, SN; Karmeli, F; Rachmilewitz, D, 2001) |
| "Colitis was more severe in rats subjected to neonatal or adult capsaicin treatment, but was not affected by subdiaphragmatic vagotomy." | 1.31 | Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents. ( Barada, KA; Kafrouni, MI; Khoury, CI; Mourad, FH; Nassar, CF; Saade, NE; Szabo, SS, 2001) |
| "We tried to produce a new ulcerative colitis model in rats by topical administration of sulfhydryl blockers." | 1.30 | New ulcerative colitis model induced by sulfhydryl blockers in rats and the effects of antiinflammatory drugs on the colitis. ( Sato, F; Satoh, H; Szabo, S; Takami, K, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 13 (50.00) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Zou, X | 1 |
| Wang, Y | 2 |
| Yang, J | 1 |
| Guo, H | 1 |
| Cai, Z | 1 |
| Hagiwara, SI | 1 |
| Kaushal, E | 1 |
| Paruthiyil, S | 1 |
| Pasricha, PJ | 2 |
| Hasdemir, B | 1 |
| Bhargava, A | 1 |
| Tolstanova, G | 3 |
| Deng, X | 3 |
| Ahluwalia, A | 2 |
| Paunovic, B | 2 |
| Prysiazhniuk, A | 1 |
| Ostapchenko, L | 1 |
| Tarnawski, A | 2 |
| Sandor, Z | 4 |
| Szabo, S | 5 |
| Hajj Hussein, IA | 1 |
| Tohme, R | 1 |
| Barada, K | 2 |
| Mostafa, MH | 1 |
| Freund, JN | 1 |
| Jurjus, RA | 1 |
| Karam, W | 1 |
| Jurjus, A | 2 |
| Khomenko, T | 2 |
| Chen, L | 2 |
| Krolczyk, G | 1 |
| Gil, K | 1 |
| Zurowski, D | 1 |
| Jung, A | 1 |
| Thor, PJ | 1 |
| Garg, P | 1 |
| Sitaraman, SV | 1 |
| Shiloach, J | 1 |
| Jagtap, AG | 1 |
| Niphadkar, PV | 1 |
| Phadke, AS | 1 |
| Ozaki, N | 1 |
| Bielefeldt, K | 1 |
| Sengupta, JN | 1 |
| Gebhart, GF | 1 |
| Shibolet, O | 1 |
| Karmeli, F | 7 |
| Eliakim, R | 3 |
| Swennen, E | 1 |
| Brigidi, P | 1 |
| Gionchetti, P | 1 |
| Campieri, M | 1 |
| Morgenstern, S | 1 |
| Rachmilewitz, D | 7 |
| Ackerman, Z | 1 |
| Cohen, P | 3 |
| Pérez-Navarro, R | 1 |
| Ballester, I | 1 |
| Zarzuelo, A | 1 |
| Sánchez de Medina, F | 1 |
| Khoury, N | 1 |
| Assef, MD | 1 |
| Foltzer, CJ | 1 |
| Reimund, JM | 1 |
| Kedinger, M | 1 |
| Elseweidy, MM | 1 |
| Younis, NN | 1 |
| Amin, RS | 1 |
| Abdallah, FR | 1 |
| Fathy, AM | 1 |
| Yousif, ZA | 1 |
| Liu, LS | 1 |
| Winston, JH | 1 |
| Shenoy, MM | 1 |
| Song, GQ | 1 |
| Chen, JD | 1 |
| Kusstatscher, S | 1 |
| Szeli, D | 1 |
| Dial, EJ | 1 |
| Hall, LR | 1 |
| Romero, JJ | 1 |
| Lichtenberger, LM | 1 |
| Satoh, H | 1 |
| Sato, F | 1 |
| Takami, K | 1 |
| Okon, E | 2 |
| Shao, JS | 1 |
| Alpers, DH | 1 |
| Ablin, J | 1 |
| Shalev, O | 1 |
| Heyman, SN | 1 |
| Dotan, I | 1 |
| Hershkoviz, R | 1 |
| Brazowski, E | 1 |
| Peled, Y | 1 |
| Halpern, Z | 1 |
| Barada, KA | 1 |
| Kafrouni, MI | 1 |
| Khoury, CI | 1 |
| Saade, NE | 1 |
| Mourad, FH | 1 |
| Szabo, SS | 1 |
| Nassar, CF | 1 |
26 other studies available for iodoacetamide and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Paeoniflorin Alleviates Abnormalities in Rats with Functional Dyspepsia by Stimulating the Release of Acetylcholine.
Topics: Acetylcholine; Animals; Clonidine; Disease Models, Animal; Dyspepsia; Glucosides; Iodoacetamide; Mal | 2020 |
Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia.
Topics: Animals; Behavior, Animal; Cell Count; Corticotropin-Releasing Hormone; Disease Models, Animal; Dysp | 2018 |
Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease.
Topics: Animals; Biopsy, Needle; Blotting, Western; Cabergoline; Capillary Permeability; Colitis, Ulcerative | 2015 |
Inflammatory bowel disease in rats: bacterial and chemical interaction.
Topics: Animals; Colitis, Ulcerative; Colon, Descending; Disease Models, Animal; Enteropathogenic Escherichi | 2008 |
Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF.
Topics: Animals; Antibodies; Cell Membrane Permeability; Colitis, Ulcerative; Colon; Disease Models, Animal; | 2009 |
The vagal afferents discharge and myoelectrical activity in the gastric hyperalgesia model in rats.
Topics: Animals; Disease Models, Animal; Duodenum; Electromyography; Fourier Analysis; Gastric Mucosa; Gastr | 2008 |
Role of anti-angiogenic factor endostatin in the pathogenesis of experimental ulcerative colitis.
Topics: Animals; Blotting, Western; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; End | 2011 |
Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice.
Topics: Acetic Acid; Animals; Bombax; Colitis; Disease Models, Animal; Female; India; Indomethacin; Inflamma | 2011 |
Models of gastric hyperalgesia in the rat.
Topics: Acetic Acid; Animals; Avoidance Learning; Behavior, Animal; Catheterization; Disease Models, Animal; | 2002 |
Variable response to probiotics in two models of experimental colitis in rats.
Topics: Alkylating Agents; Animals; Benzenesulfonates; Bifidobacterium; Colitis; Disease Models, Animal; Int | 2002 |
Experimental colitis in rats with portal hypertension and liver disease.
Topics: Alkylating Agents; Amino Acids; Animals; Bile Ducts; Colitis; Disease Models, Animal; Hemodynamics; | 2003 |
Disturbances in epithelial ionic secretion in different experimental models of colitis.
Topics: Acetic Acid; Acute Disease; Alkylating Agents; Animals; Animals, Genetically Modified; Chloramines; | 2005 |
Morphological and biochemical alterations in the jejunum following iodoacetamide-induced colitis in rats.
Topics: Aminopeptidases; Animals; Colitis; Colon; Disease Models, Animal; Female; Gene Expression Regulation | 2006 |
Effect of some natural products either alone or in combination on gastritis induced in experimental rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Curcuma; Disease Models, Animal; Fatty Acids, O | 2008 |
A rat model of chronic gastric sensorimotor dysfunction resulting from transient neonatal gastric irritation.
Topics: Age Factors; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Catheterization; Chronic Dise | 2008 |
[The effect of thrombocyte-derived growth factor on experimental inflammatory bowel disease].
Topics: Animals; Disease Models, Animal; Inflammatory Bowel Diseases; Iodoacetamide; Platelet-Derived Growth | 1995 |
Rats with gastritis have increased sensitivity to the gastrin stimulatory effects of luminal ammonia.
Topics: Acetates; Ammonia; Animals; Disease Models, Animal; Gastric Mucosa; Gastrins; Gastritis; Iodoacetami | 1996 |
New ulcerative colitis model induced by sulfhydryl blockers in rats and the effects of antiinflammatory drugs on the colitis.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoquinones; Colitis, | 1997 |
Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohn's disease.
Topics: Acetophenones; Animals; Antioxidants; Crohn Disease; Cyclic N-Oxides; Disease Models, Animal; Enteri | 1997 |
Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle.
Topics: Animals; Antibodies; Colitis; Disease Models, Animal; Enteritis; Injections, Intravenous; Intestinal | 1999 |
Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats.
Topics: Acetates; Administration, Oral; Animals; Colitis; Deferiprone; Disease Models, Animal; Gastric Mucos | 1999 |
Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats.
Topics: Animals; Colitis; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Admin | 2001 |
Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Benzenesulfonates; Colitis; Disease Models, Anima | 2001 |
Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents.
Topics: Afferent Pathways; Alanine; Animals; Animals, Newborn; Capsaicin; Colitis; Denervation; Disease Mode | 2001 |